| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Infant Formula | 28 | 2023 | 147 | 7.220 |
Why?
|
| Soybean Proteins | 45 | 2020 | 161 | 6.790 |
Why?
|
| Ethanol | 70 | 2016 | 336 | 6.250 |
Why?
|
| Breast Feeding | 22 | 2023 | 189 | 4.780 |
Why?
|
| Liver | 57 | 2018 | 1132 | 4.420 |
Why?
|
| Child Development | 14 | 2018 | 192 | 4.080 |
Why?
|
| Diet | 45 | 2020 | 568 | 4.020 |
Why?
|
| Rats | 185 | 2016 | 3292 | 3.610 |
Why?
|
| Rats, Sprague-Dawley | 125 | 2018 | 1585 | 3.510 |
Why?
|
| Isoflavones | 24 | 2022 | 89 | 3.500 |
Why?
|
| Animals | 246 | 2023 | 13124 | 3.210 |
Why?
|
| Infant Nutritional Physiological Phenomena | 9 | 2016 | 55 | 2.830 |
Why?
|
| Milk | 13 | 2023 | 80 | 2.820 |
Why?
|
| Estradiol | 30 | 2019 | 221 | 2.670 |
Why?
|
| Milk, Human | 11 | 2023 | 106 | 2.640 |
Why?
|
| Cytochrome P-450 Enzyme System | 27 | 2014 | 194 | 2.400 |
Why?
|
| Obesity | 26 | 2021 | 1121 | 2.360 |
Why?
|
| Male | 200 | 2023 | 25910 | 1.980 |
Why?
|
| Adipose Tissue | 9 | 2019 | 192 | 1.980 |
Why?
|
| Body Composition | 14 | 2020 | 327 | 1.940 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 14 | 2006 | 74 | 1.900 |
Why?
|
| Gene Expression Regulation | 25 | 2016 | 955 | 1.890 |
Why?
|
| Soy Milk | 10 | 2018 | 37 | 1.870 |
Why?
|
| Female | 168 | 2023 | 27086 | 1.800 |
Why?
|
| Brain | 19 | 2023 | 1323 | 1.690 |
Why?
|
| Chromatography, Liquid | 11 | 2016 | 231 | 1.640 |
Why?
|
| Mass Spectrometry | 10 | 2016 | 285 | 1.630 |
Why?
|
| Dietary Fats | 10 | 2014 | 125 | 1.630 |
Why?
|
| Cytochrome P-450 CYP2E1 | 26 | 2014 | 111 | 1.600 |
Why?
|
| RNA, Messenger | 48 | 2016 | 1089 | 1.590 |
Why?
|
| Genistein | 16 | 2022 | 46 | 1.550 |
Why?
|
| Bottle Feeding | 8 | 2020 | 34 | 1.550 |
Why?
|
| Infant | 32 | 2023 | 3630 | 1.550 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 8 | 2016 | 50 | 1.520 |
Why?
|
| Fatty Liver | 10 | 2014 | 130 | 1.490 |
Why?
|
| Adiposity | 8 | 2019 | 137 | 1.470 |
Why?
|
| Dietary Proteins | 16 | 2012 | 252 | 1.460 |
Why?
|
| Oxidoreductases, N-Demethylating | 14 | 2004 | 32 | 1.420 |
Why?
|
| Speech Perception | 4 | 2016 | 91 | 1.410 |
Why?
|
| Dietary Carbohydrates | 8 | 2014 | 91 | 1.320 |
Why?
|
| Milk Proteins | 14 | 2017 | 77 | 1.310 |
Why?
|
| Alcohol Dehydrogenase | 13 | 2010 | 37 | 1.250 |
Why?
|
| Pregnancy | 45 | 2023 | 2451 | 1.240 |
Why?
|
| Central Nervous System Depressants | 16 | 2013 | 80 | 1.240 |
Why?
|
| Mammary Glands, Animal | 10 | 2013 | 69 | 1.210 |
Why?
|
| Caseins | 16 | 2015 | 78 | 1.190 |
Why?
|
| Swine | 20 | 2022 | 408 | 1.160 |
Why?
|
| Overweight | 4 | 2017 | 215 | 1.060 |
Why?
|
| Phytoestrogens | 4 | 2018 | 22 | 1.060 |
Why?
|
| Magnetic Resonance Imaging | 8 | 2021 | 1555 | 1.030 |
Why?
|
| Diet, High-Fat | 9 | 2019 | 214 | 1.020 |
Why?
|
| Enteral Nutrition | 15 | 2014 | 150 | 1.020 |
Why?
|
| Osteoblasts | 16 | 2015 | 462 | 1.010 |
Why?
|
| Uterus | 5 | 2016 | 85 | 1.010 |
Why?
|
| Cell Differentiation | 18 | 2015 | 640 | 0.990 |
Why?
|
| Infant Food | 6 | 2020 | 28 | 0.960 |
Why?
|
| Bone Density | 15 | 2016 | 387 | 0.960 |
Why?
|
| Evoked Potentials | 3 | 2016 | 69 | 0.960 |
Why?
|
| Infant, Newborn | 22 | 2023 | 2747 | 0.940 |
Why?
|
| Humans | 108 | 2023 | 50509 | 0.930 |
Why?
|
| Prenatal Exposure Delayed Effects | 13 | 2011 | 182 | 0.920 |
Why?
|
| Vagus Nerve | 2 | 2015 | 22 | 0.910 |
Why?
|
| Insulin | 8 | 2014 | 467 | 0.910 |
Why?
|
| Homeostasis | 7 | 2014 | 204 | 0.910 |
Why?
|
| Evoked Potentials, Auditory | 3 | 2011 | 90 | 0.890 |
Why?
|
| Weight Gain | 13 | 2019 | 237 | 0.890 |
Why?
|
| Sex Characteristics | 7 | 2013 | 198 | 0.870 |
Why?
|
| Liver Diseases, Alcoholic | 9 | 2014 | 33 | 0.870 |
Why?
|
| Testis | 9 | 2018 | 66 | 0.870 |
Why?
|
| Luteinizing Hormone | 35 | 1998 | 49 | 0.850 |
Why?
|
| Adiponectin | 3 | 2019 | 46 | 0.850 |
Why?
|
| Sex Factors | 10 | 2018 | 712 | 0.810 |
Why?
|
| Enzyme Induction | 16 | 2010 | 79 | 0.800 |
Why?
|
| Testosterone | 32 | 2007 | 145 | 0.770 |
Why?
|
| Cholesterol | 4 | 2011 | 150 | 0.770 |
Why?
|
| Signal Transduction | 24 | 2019 | 1624 | 0.770 |
Why?
|
| Animals, Newborn | 18 | 2018 | 363 | 0.760 |
Why?
|
| Soy Foods | 4 | 2016 | 20 | 0.750 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 6 | 2014 | 16 | 0.750 |
Why?
|
| Body Weight | 22 | 2016 | 517 | 0.740 |
Why?
|
| Serum | 4 | 2018 | 32 | 0.740 |
Why?
|
| Pregnancy Complications | 8 | 2017 | 380 | 0.730 |
Why?
|
| Growth Hormone | 18 | 2000 | 97 | 0.720 |
Why?
|
| Blotting, Western | 20 | 2016 | 578 | 0.720 |
Why?
|
| Lipid Metabolism | 8 | 2017 | 175 | 0.710 |
Why?
|
| Infant Behavior | 2 | 2012 | 18 | 0.710 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 18 | 2016 | 572 | 0.700 |
Why?
|
| Gene Expression | 12 | 2013 | 610 | 0.690 |
Why?
|
| Carcinogens | 7 | 2015 | 196 | 0.690 |
Why?
|
| Kidney | 8 | 2007 | 696 | 0.690 |
Why?
|
| Cell Division | 13 | 2010 | 291 | 0.690 |
Why?
|
| Colonic Neoplasms | 6 | 2007 | 158 | 0.690 |
Why?
|
| Diffusion Tensor Imaging | 7 | 2022 | 93 | 0.680 |
Why?
|
| Gene Expression Regulation, Enzymologic | 11 | 2010 | 179 | 0.680 |
Why?
|
| PPAR alpha | 7 | 2016 | 56 | 0.670 |
Why?
|
| Inflammation | 10 | 2017 | 610 | 0.670 |
Why?
|
| Fatty Acids | 8 | 2014 | 144 | 0.660 |
Why?
|
| Cytochrome P-450 CYP3A | 9 | 2010 | 77 | 0.640 |
Why?
|
| Tumor Necrosis Factor-alpha | 14 | 2016 | 393 | 0.640 |
Why?
|
| Cytokines | 11 | 2017 | 606 | 0.640 |
Why?
|
| Child | 21 | 2023 | 6910 | 0.640 |
Why?
|
| Longitudinal Studies | 8 | 2018 | 734 | 0.630 |
Why?
|
| Organ Size | 17 | 2015 | 225 | 0.630 |
Why?
|
| GABAergic Neurons | 1 | 2018 | 10 | 0.620 |
Why?
|
| Promoter Regions, Genetic | 8 | 2014 | 465 | 0.620 |
Why?
|
| Bone Resorption | 10 | 2014 | 302 | 0.620 |
Why?
|
| DNA-Binding Proteins | 4 | 2009 | 418 | 0.610 |
Why?
|
| Food, Formulated | 4 | 2023 | 42 | 0.610 |
Why?
|
| Agouti Signaling Protein | 2 | 2008 | 5 | 0.600 |
Why?
|
| Transcriptome | 8 | 2018 | 314 | 0.590 |
Why?
|
| Cell Proliferation | 11 | 2016 | 985 | 0.590 |
Why?
|
| Mice | 28 | 2019 | 5687 | 0.590 |
Why?
|
| Growth | 7 | 2020 | 40 | 0.590 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 3 | 2014 | 55 | 0.580 |
Why?
|
| Cerebral Cortex | 2 | 2016 | 198 | 0.570 |
Why?
|
| Bone Diseases, Metabolic | 3 | 2016 | 74 | 0.570 |
Why?
|
| Dietary Supplements | 4 | 2014 | 449 | 0.560 |
Why?
|
| Antineoplastic Agents, Phytogenic | 3 | 2006 | 66 | 0.560 |
Why?
|
| Down-Regulation | 8 | 2016 | 340 | 0.560 |
Why?
|
| Bone Development | 8 | 2015 | 65 | 0.550 |
Why?
|
| Triglycerides | 4 | 2017 | 160 | 0.550 |
Why?
|
| Cytochrome P-450 CYP1A1 | 7 | 2008 | 26 | 0.550 |
Why?
|
| Gestational Age | 2 | 2019 | 373 | 0.550 |
Why?
|
| Mammary Neoplasms, Experimental | 5 | 2006 | 121 | 0.540 |
Why?
|
| Phonetics | 4 | 2011 | 47 | 0.540 |
Why?
|
| Steroid 16-alpha-Hydroxylase | 5 | 2003 | 10 | 0.540 |
Why?
|
| Chenodeoxycholic Acid | 1 | 2016 | 7 | 0.540 |
Why?
|
| Osteogenesis | 13 | 2016 | 356 | 0.530 |
Why?
|
| Microsomes, Liver | 7 | 2005 | 183 | 0.530 |
Why?
|
| Disease Models, Animal | 15 | 2016 | 1436 | 0.530 |
Why?
|
| Endocrine System | 5 | 2009 | 16 | 0.530 |
Why?
|
| Parenteral Nutrition, Total | 7 | 2010 | 31 | 0.520 |
Why?
|
| Cattle | 8 | 2020 | 205 | 0.520 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2016 | 24 | 0.510 |
Why?
|
| Mothers | 4 | 2023 | 257 | 0.510 |
Why?
|
| Anticarcinogenic Agents | 6 | 2006 | 32 | 0.510 |
Why?
|
| Cytochrome P-450 CYP1A2 | 4 | 2008 | 38 | 0.500 |
Why?
|
| Sulfates | 3 | 2006 | 24 | 0.500 |
Why?
|
| Transcription, Genetic | 9 | 2012 | 361 | 0.500 |
Why?
|
| Placenta | 5 | 2014 | 134 | 0.500 |
Why?
|
| Protein Hydrolysates | 1 | 2015 | 6 | 0.500 |
Why?
|
| Genitalia, Male | 2 | 2015 | 13 | 0.490 |
Why?
|
| Isoenzymes | 8 | 2005 | 168 | 0.490 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2015 | 35 | 0.490 |
Why?
|
| Sexual Development | 1 | 2015 | 6 | 0.490 |
Why?
|
| Hormones | 5 | 2007 | 57 | 0.480 |
Why?
|
| Genitalia, Female | 1 | 2015 | 18 | 0.480 |
Why?
|
| Child of Impaired Parents | 1 | 2015 | 42 | 0.470 |
Why?
|
| Atherosclerosis | 4 | 2011 | 217 | 0.470 |
Why?
|
| Adipocytes | 4 | 2014 | 126 | 0.470 |
Why?
|
| Body Fluids | 1 | 2014 | 20 | 0.470 |
Why?
|
| Dose-Response Relationship, Drug | 25 | 2013 | 1372 | 0.470 |
Why?
|
| Trace Elements | 1 | 2014 | 9 | 0.470 |
Why?
|
| Acetylcysteine | 7 | 2010 | 101 | 0.470 |
Why?
|
| Osteogenesis, Distraction | 9 | 2007 | 78 | 0.460 |
Why?
|
| Gonadotropin-Releasing Hormone | 22 | 1988 | 39 | 0.460 |
Why?
|
| Metabolome | 3 | 2020 | 94 | 0.460 |
Why?
|
| Gene Expression Profiling | 14 | 2017 | 1025 | 0.460 |
Why?
|
| Autonomic Nervous System | 1 | 2015 | 58 | 0.460 |
Why?
|
| Apolipoproteins E | 3 | 2011 | 58 | 0.460 |
Why?
|
| Alcoholism | 6 | 2008 | 235 | 0.460 |
Why?
|
| Time Factors | 34 | 2014 | 2934 | 0.460 |
Why?
|
| Zinc | 1 | 2014 | 52 | 0.450 |
Why?
|
| Oxidative Stress | 12 | 2014 | 772 | 0.450 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2014 | 238 | 0.440 |
Why?
|
| Hippurates | 1 | 2014 | 10 | 0.440 |
Why?
|
| Cell Membrane | 2 | 2006 | 246 | 0.440 |
Why?
|
| Aging | 10 | 2016 | 694 | 0.440 |
Why?
|
| Glucuronides | 3 | 2002 | 45 | 0.440 |
Why?
|
| Rest | 2 | 2016 | 63 | 0.430 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 2 | 2004 | 14 | 0.430 |
Why?
|
| Steroid Hydroxylases | 8 | 2007 | 18 | 0.420 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2013 | 244 | 0.410 |
Why?
|
| Electroencephalography | 6 | 2016 | 308 | 0.410 |
Why?
|
| Leptin | 6 | 2019 | 143 | 0.410 |
Why?
|
| Intestine, Small | 4 | 2017 | 110 | 0.410 |
Why?
|
| Dexamethasone | 4 | 2010 | 432 | 0.410 |
Why?
|
| Estrogens | 7 | 2013 | 226 | 0.410 |
Why?
|
| Reproduction | 4 | 2022 | 56 | 0.400 |
Why?
|
| Hepatocytes | 3 | 2008 | 178 | 0.400 |
Why?
|
| Ergosterol | 3 | 1998 | 10 | 0.400 |
Why?
|
| Colon | 5 | 2017 | 97 | 0.390 |
Why?
|
| Apoptosis | 9 | 2012 | 1097 | 0.390 |
Why?
|
| Reactive Oxygen Species | 7 | 2016 | 409 | 0.390 |
Why?
|
| Cognition | 5 | 2022 | 346 | 0.380 |
Why?
|
| Analysis of Variance | 8 | 2014 | 552 | 0.380 |
Why?
|
| Insulin Resistance | 7 | 2016 | 268 | 0.380 |
Why?
|
| Blastocyst | 1 | 2011 | 10 | 0.380 |
Why?
|
| Age Factors | 8 | 2014 | 1110 | 0.380 |
Why?
|
| Growth Hormone-Releasing Hormone | 7 | 1997 | 27 | 0.370 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2009 | 68 | 0.370 |
Why?
|
| Animal Feed | 6 | 2018 | 56 | 0.360 |
Why?
|
| Absorptiometry, Photon | 5 | 2020 | 156 | 0.360 |
Why?
|
| Health | 3 | 2010 | 23 | 0.360 |
Why?
|
| Heart | 1 | 2013 | 341 | 0.360 |
Why?
|
| Lipid Peroxidation | 5 | 2016 | 96 | 0.360 |
Why?
|
| Hyperinsulinism | 1 | 2011 | 27 | 0.360 |
Why?
|
| Anisotropy | 4 | 2022 | 64 | 0.360 |
Why?
|
| Receptors, Steroid | 1 | 2010 | 19 | 0.360 |
Why?
|
| Umbilical Cord | 3 | 2017 | 33 | 0.360 |
Why?
|
| Social Isolation | 1 | 2010 | 28 | 0.350 |
Why?
|
| Alcohol Drinking | 3 | 2014 | 227 | 0.350 |
Why?
|
| Iron | 1 | 2011 | 121 | 0.350 |
Why?
|
| Cohort Studies | 6 | 2018 | 1452 | 0.350 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 8 | 2013 | 405 | 0.350 |
Why?
|
| Breast Neoplasms | 7 | 2006 | 1201 | 0.350 |
Why?
|
| Fatty Liver, Alcoholic | 1 | 2010 | 7 | 0.340 |
Why?
|
| Glucuronidase | 3 | 2005 | 48 | 0.340 |
Why?
|
| Mice, Inbred C57BL | 14 | 2019 | 1808 | 0.340 |
Why?
|
| Deafness | 1 | 2010 | 31 | 0.340 |
Why?
|
| Gastrointestinal Neoplasms | 2 | 2003 | 40 | 0.330 |
Why?
|
| Blotting, Northern | 7 | 2006 | 110 | 0.330 |
Why?
|
| Genitalia | 1 | 2009 | 11 | 0.330 |
Why?
|
| Malnutrition | 3 | 2007 | 85 | 0.330 |
Why?
|
| Child, Preschool | 11 | 2021 | 3944 | 0.330 |
Why?
|
| Plant Proteins | 2 | 2008 | 68 | 0.330 |
Why?
|
| PPAR gamma | 6 | 2014 | 65 | 0.330 |
Why?
|
| Antioxidants | 6 | 2016 | 239 | 0.330 |
Why?
|
| Mice, Knockout | 8 | 2019 | 844 | 0.320 |
Why?
|
| Chemokine CCL2 | 2 | 2016 | 68 | 0.320 |
Why?
|
| Breast | 1 | 2009 | 85 | 0.320 |
Why?
|
| Protein Kinases | 2 | 2007 | 71 | 0.310 |
Why?
|
| Docosahexaenoic Acids | 1 | 2009 | 29 | 0.310 |
Why?
|
| Cells, Cultured | 18 | 2016 | 1571 | 0.310 |
Why?
|
| Hair Color | 1 | 2008 | 10 | 0.310 |
Why?
|
| Proliferating Cell Nuclear Antigen | 10 | 2016 | 68 | 0.310 |
Why?
|
| Oligopeptides | 5 | 1997 | 95 | 0.310 |
Why?
|
| Pituitary Gland, Anterior | 9 | 1993 | 35 | 0.310 |
Why?
|
| Wnt Proteins | 5 | 2013 | 98 | 0.300 |
Why?
|
| Phenotype | 4 | 2014 | 739 | 0.300 |
Why?
|
| Sulfatases | 2 | 2005 | 6 | 0.300 |
Why?
|
| Lead | 5 | 2001 | 34 | 0.300 |
Why?
|
| Glucose | 4 | 2016 | 341 | 0.300 |
Why?
|
| Ovariectomy | 9 | 2016 | 115 | 0.290 |
Why?
|
| Hepatitis | 1 | 2008 | 21 | 0.290 |
Why?
|
| Liver Neoplasms, Experimental | 3 | 2014 | 50 | 0.290 |
Why?
|
| Immunohistochemistry | 10 | 2016 | 957 | 0.290 |
Why?
|
| Depression | 2 | 2023 | 582 | 0.290 |
Why?
|
| Cell Line | 10 | 2014 | 988 | 0.280 |
Why?
|
| Heart Rate | 1 | 2009 | 307 | 0.280 |
Why?
|
| Chemoprevention | 2 | 2004 | 15 | 0.280 |
Why?
|
| Receptors, Aryl Hydrocarbon | 5 | 2008 | 26 | 0.280 |
Why?
|
| Osteocalcin | 4 | 2023 | 43 | 0.280 |
Why?
|
| Fungicides, Industrial | 2 | 1998 | 7 | 0.280 |
Why?
|
| Interleukin-6 | 5 | 2016 | 261 | 0.280 |
Why?
|
| Lipids | 5 | 2010 | 152 | 0.270 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2016 | 156 | 0.270 |
Why?
|
| Triterpenes | 2 | 2005 | 11 | 0.270 |
Why?
|
| Necrosis | 5 | 2013 | 174 | 0.270 |
Why?
|
| Adipogenesis | 4 | 2016 | 49 | 0.270 |
Why?
|
| Alkylating Agents | 2 | 2014 | 23 | 0.270 |
Why?
|
| Saponins | 2 | 2004 | 6 | 0.270 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2006 | 62 | 0.260 |
Why?
|
| Azoxymethane | 5 | 2007 | 11 | 0.260 |
Why?
|
| Microsomes | 4 | 1999 | 35 | 0.260 |
Why?
|
| Androgens | 7 | 2018 | 70 | 0.260 |
Why?
|
| Receptors, Progesterone | 3 | 2004 | 64 | 0.260 |
Why?
|
| Methylnitrosourea | 3 | 2006 | 10 | 0.260 |
Why?
|
| Shiitake Mushrooms | 1 | 2006 | 5 | 0.260 |
Why?
|
| Animals, Suckling | 3 | 2017 | 15 | 0.260 |
Why?
|
| Bone and Bones | 8 | 2015 | 478 | 0.260 |
Why?
|
| Alanine Transaminase | 5 | 2014 | 119 | 0.260 |
Why?
|
| Caveolin 1 | 3 | 2014 | 21 | 0.260 |
Why?
|
| DNA Methylation | 3 | 2017 | 550 | 0.260 |
Why?
|
| Monocytes | 1 | 2006 | 127 | 0.250 |
Why?
|
| Acetates | 1 | 2006 | 49 | 0.250 |
Why?
|
| beta Catenin | 3 | 2010 | 97 | 0.250 |
Why?
|
| Follicle Stimulating Hormone | 17 | 1990 | 40 | 0.250 |
Why?
|
| Beer | 1 | 2005 | 3 | 0.250 |
Why?
|
| Estrogen Receptor alpha | 4 | 2016 | 88 | 0.240 |
Why?
|
| Intelligence Tests | 2 | 2015 | 44 | 0.240 |
Why?
|
| Estrogens, Non-Steroidal | 3 | 2007 | 16 | 0.240 |
Why?
|
| Beverages | 2 | 2002 | 56 | 0.240 |
Why?
|
| Glutathione Transferase | 2 | 2016 | 172 | 0.240 |
Why?
|
| Coumaric Acids | 2 | 2011 | 8 | 0.240 |
Why?
|
| Gastrointestinal Tract | 1 | 2006 | 103 | 0.240 |
Why?
|
| Lysophospholipids | 2 | 2008 | 44 | 0.230 |
Why?
|
| Birth Weight | 4 | 2015 | 106 | 0.230 |
Why?
|
| Endothelial Cells | 1 | 2006 | 258 | 0.230 |
Why?
|
| Endotoxins | 1 | 2004 | 31 | 0.230 |
Why?
|
| Aldehydes | 3 | 2014 | 82 | 0.230 |
Why?
|
| Carbohydrates | 1 | 2004 | 38 | 0.230 |
Why?
|
| NF-kappa B | 3 | 2011 | 315 | 0.230 |
Why?
|
| Orphan Nuclear Receptors | 3 | 2010 | 14 | 0.230 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2004 | 24 | 0.220 |
Why?
|
| Language Development | 2 | 2016 | 28 | 0.220 |
Why?
|
| Tibia | 11 | 2016 | 119 | 0.220 |
Why?
|
| Adult | 25 | 2019 | 13583 | 0.220 |
Why?
|
| Immunoprecipitation | 5 | 2013 | 59 | 0.220 |
Why?
|
| Colinus | 3 | 1998 | 3 | 0.220 |
Why?
|
| Pituitary Gland | 12 | 1999 | 85 | 0.220 |
Why?
|
| Alcohols | 1 | 2003 | 8 | 0.210 |
Why?
|
| Phytosterols | 1 | 2003 | 5 | 0.210 |
Why?
|
| Insulin-Like Growth Factor I | 9 | 2019 | 136 | 0.210 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2003 | 88 | 0.210 |
Why?
|
| Membrane Glycoproteins | 2 | 2015 | 245 | 0.210 |
Why?
|
| Ovary | 2 | 2016 | 103 | 0.210 |
Why?
|
| Alcoholic Intoxication | 1 | 2003 | 19 | 0.210 |
Why?
|
| Oleanolic Acid | 1 | 2002 | 4 | 0.210 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2003 | 145 | 0.210 |
Why?
|
| Executive Function | 2 | 2020 | 76 | 0.210 |
Why?
|
| Models, Animal | 7 | 2014 | 227 | 0.200 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2002 | 4 | 0.200 |
Why?
|
| Real-Time Polymerase Chain Reaction | 5 | 2016 | 181 | 0.200 |
Why?
|
| Child Language | 2 | 2014 | 11 | 0.200 |
Why?
|
| Apoproteins | 5 | 2005 | 14 | 0.200 |
Why?
|
| Nutrition Surveys | 1 | 2023 | 113 | 0.200 |
Why?
|
| Fruit | 3 | 2012 | 119 | 0.200 |
Why?
|
| Cell Line, Tumor | 6 | 2006 | 1398 | 0.200 |
Why?
|
| Language | 3 | 2021 | 138 | 0.200 |
Why?
|
| Lactation | 4 | 2012 | 58 | 0.200 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 3 | 2022 | 125 | 0.200 |
Why?
|
| Plethysmography | 2 | 2012 | 43 | 0.190 |
Why?
|
| Administration, Oral | 7 | 2006 | 434 | 0.190 |
Why?
|
| Bacteria | 3 | 2020 | 218 | 0.190 |
Why?
|
| Binding Sites | 4 | 2006 | 362 | 0.190 |
Why?
|
| Depressive Disorder, Major | 1 | 2023 | 151 | 0.190 |
Why?
|
| Interleukin-1 | 5 | 2005 | 105 | 0.190 |
Why?
|
| Memory | 2 | 2020 | 115 | 0.190 |
Why?
|
| Body Water | 2 | 2012 | 24 | 0.190 |
Why?
|
| Models, Biological | 6 | 2014 | 716 | 0.190 |
Why?
|
| Safrole | 1 | 2001 | 4 | 0.190 |
Why?
|
| Methylcholanthrene | 1 | 2001 | 10 | 0.190 |
Why?
|
| Prostatic Neoplasms | 1 | 2005 | 384 | 0.180 |
Why?
|
| Chelating Agents | 1 | 2001 | 28 | 0.180 |
Why?
|
| Tumor Cells, Cultured | 5 | 2006 | 457 | 0.180 |
Why?
|
| Weaning | 5 | 2014 | 28 | 0.180 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2012 | 234 | 0.180 |
Why?
|
| Urinalysis | 1 | 2020 | 33 | 0.180 |
Why?
|
| Periodicity | 1 | 2000 | 23 | 0.180 |
Why?
|
| Ultrasonography | 2 | 2015 | 435 | 0.180 |
Why?
|
| Neuropsychological Tests | 3 | 2020 | 355 | 0.180 |
Why?
|
| Prospective Studies | 4 | 2019 | 2378 | 0.170 |
Why?
|
| Body Mass Index | 2 | 2015 | 677 | 0.170 |
Why?
|
| Liver Regeneration | 4 | 2010 | 47 | 0.170 |
Why?
|
| Osteoporosis | 2 | 2012 | 156 | 0.170 |
Why?
|
| Enzyme Inhibitors | 4 | 2010 | 377 | 0.170 |
Why?
|
| Malondialdehyde | 3 | 2005 | 51 | 0.170 |
Why?
|
| Macrophages | 4 | 2011 | 364 | 0.170 |
Why?
|
| Energy Metabolism | 3 | 2013 | 286 | 0.170 |
Why?
|
| Cytochrome P-450 CYP2B1 | 1 | 1999 | 6 | 0.170 |
Why?
|
| Parents | 2 | 2020 | 318 | 0.170 |
Why?
|
| Brain Mapping | 3 | 2021 | 232 | 0.170 |
Why?
|
| Oxygenases | 3 | 1999 | 14 | 0.170 |
Why?
|
| Hypercholesterolemia | 2 | 2010 | 38 | 0.170 |
Why?
|
| Overnutrition | 2 | 2011 | 10 | 0.160 |
Why?
|
| Feces | 1 | 2020 | 134 | 0.160 |
Why?
|
| Receptor Cross-Talk | 1 | 2019 | 7 | 0.160 |
Why?
|
| Hypogonadism | 5 | 1988 | 10 | 0.160 |
Why?
|
| NADH, NADPH Oxidoreductases | 1 | 1999 | 13 | 0.160 |
Why?
|
| Follow-Up Studies | 2 | 2016 | 2241 | 0.160 |
Why?
|
| Early Growth Response Protein 1 | 2 | 2016 | 34 | 0.160 |
Why?
|
| Rats, Inbred Strains | 15 | 1992 | 197 | 0.160 |
Why?
|
| Hepatitis, Alcoholic | 1 | 1999 | 10 | 0.160 |
Why?
|
| Growth Disorders | 2 | 1997 | 62 | 0.160 |
Why?
|
| Immunity, Humoral | 1 | 2018 | 22 | 0.150 |
Why?
|
| Antigens, CD | 3 | 2016 | 222 | 0.150 |
Why?
|
| RANK Ligand | 4 | 2013 | 187 | 0.150 |
Why?
|
| Energy Intake | 4 | 2008 | 176 | 0.150 |
Why?
|
| Immunity, Cellular | 1 | 2018 | 63 | 0.150 |
Why?
|
| Purines | 1 | 2018 | 37 | 0.150 |
Why?
|
| Urogenital System | 1 | 1998 | 5 | 0.150 |
Why?
|
| Osteoclasts | 5 | 2013 | 427 | 0.150 |
Why?
|
| Neoplasms | 2 | 2006 | 1254 | 0.150 |
Why?
|
| Random Allocation | 6 | 2016 | 289 | 0.150 |
Why?
|
| Spectrum Analysis | 2 | 2009 | 71 | 0.150 |
Why?
|
| Acetone | 1 | 1998 | 7 | 0.150 |
Why?
|
| Midazolam | 2 | 2010 | 37 | 0.150 |
Why?
|
| Exosomes | 1 | 2018 | 48 | 0.150 |
Why?
|
| Metabolomics | 2 | 2020 | 135 | 0.150 |
Why?
|
| Cell Nucleus | 4 | 2010 | 182 | 0.150 |
Why?
|
| Regression Analysis | 2 | 2017 | 382 | 0.150 |
Why?
|
| Base Sequence | 4 | 2013 | 639 | 0.140 |
Why?
|
| Plant Preparations | 2 | 2011 | 39 | 0.140 |
Why?
|
| Tryptamines | 1 | 2017 | 10 | 0.140 |
Why?
|
| Bone Lengthening | 2 | 1997 | 5 | 0.140 |
Why?
|
| Cadherins | 2 | 2016 | 63 | 0.140 |
Why?
|
| Follicular Fluid | 1 | 2017 | 9 | 0.140 |
Why?
|
| Bone Remodeling | 2 | 2016 | 149 | 0.140 |
Why?
|
| Circadian Rhythm | 3 | 2014 | 90 | 0.140 |
Why?
|
| Cesarean Section | 1 | 2018 | 157 | 0.140 |
Why?
|
| Anticholesteremic Agents | 2 | 2009 | 27 | 0.140 |
Why?
|
| Oocytes | 1 | 2017 | 75 | 0.140 |
Why?
|
| Hypothalamo-Hypophyseal System | 4 | 1982 | 27 | 0.140 |
Why?
|
| Tryptophan | 1 | 2017 | 100 | 0.140 |
Why?
|
| Metabolic Clearance Rate | 3 | 2007 | 69 | 0.130 |
Why?
|
| Functional Laterality | 2 | 2007 | 89 | 0.130 |
Why?
|
| Hydrogen Peroxide | 2 | 2016 | 113 | 0.130 |
Why?
|
| Gonadotropins | 6 | 1988 | 9 | 0.130 |
Why?
|
| Pregnancy, Animal | 2 | 2006 | 30 | 0.130 |
Why?
|
| C-Reactive Protein | 1 | 2017 | 144 | 0.130 |
Why?
|
| Serotonin | 1 | 2017 | 151 | 0.130 |
Why?
|
| Species Specificity | 3 | 2006 | 187 | 0.130 |
Why?
|
| Catalase | 1 | 2016 | 67 | 0.130 |
Why?
|
| Corn Oil | 2 | 2007 | 12 | 0.130 |
Why?
|
| Reaction Time | 2 | 2007 | 214 | 0.130 |
Why?
|
| Hypothalamus | 11 | 1991 | 44 | 0.130 |
Why?
|
| Feeding Behavior | 3 | 2017 | 185 | 0.130 |
Why?
|
| Prefrontal Cortex | 1 | 2016 | 86 | 0.130 |
Why?
|
| Ki-67 Antigen | 1 | 2016 | 56 | 0.130 |
Why?
|
| Chromatin Immunoprecipitation | 3 | 2010 | 48 | 0.130 |
Why?
|
| Parenteral Nutrition | 4 | 1993 | 28 | 0.130 |
Why?
|
| Parietal Lobe | 1 | 2015 | 25 | 0.130 |
Why?
|
| Sequence Analysis, RNA | 2 | 2017 | 89 | 0.130 |
Why?
|
| Visual Perception | 1 | 2015 | 36 | 0.130 |
Why?
|
| NADPH-Ferrihemoprotein Reductase | 3 | 2005 | 14 | 0.130 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2016 | 56 | 0.130 |
Why?
|
| Phosphorylation | 3 | 2010 | 525 | 0.130 |
Why?
|
| Glutathione | 3 | 2008 | 299 | 0.130 |
Why?
|
| Lymphocytes | 1 | 1996 | 149 | 0.120 |
Why?
|
| Protein Transport | 3 | 2010 | 181 | 0.120 |
Why?
|
| Phenylpropionates | 2 | 2007 | 13 | 0.120 |
Why?
|
| Fetus | 2 | 2007 | 183 | 0.120 |
Why?
|
| Nuclear Proteins | 1 | 1997 | 238 | 0.120 |
Why?
|
| Proteins | 3 | 2017 | 339 | 0.120 |
Why?
|
| Calibration | 2 | 2010 | 57 | 0.120 |
Why?
|
| Temporal Lobe | 1 | 2015 | 71 | 0.120 |
Why?
|
| Protective Agents | 1 | 2015 | 16 | 0.120 |
Why?
|
| Disease Susceptibility | 2 | 2012 | 88 | 0.120 |
Why?
|
| Injections, Intravenous | 5 | 2005 | 137 | 0.120 |
Why?
|
| Organothiophosphorus Compounds | 1 | 1995 | 6 | 0.120 |
Why?
|
| RNA | 5 | 2018 | 163 | 0.120 |
Why?
|
| Chromatography, High Pressure Liquid | 3 | 2003 | 326 | 0.120 |
Why?
|
| Insecticides | 1 | 1995 | 13 | 0.120 |
Why?
|
| Psychomotor Performance | 1 | 2015 | 130 | 0.120 |
Why?
|
| Castration | 9 | 1996 | 14 | 0.120 |
Why?
|
| MicroRNAs | 1 | 2018 | 344 | 0.120 |
Why?
|
| Plant Extracts | 2 | 2010 | 174 | 0.120 |
Why?
|
| Placentation | 1 | 2014 | 12 | 0.120 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2014 | 155 | 0.120 |
Why?
|
| Thyroid Hormones | 1 | 2014 | 20 | 0.120 |
Why?
|
| Mitochondrial Dynamics | 1 | 2014 | 21 | 0.120 |
Why?
|
| Aldehyde Dehydrogenase | 3 | 2007 | 25 | 0.120 |
Why?
|
| Free Radicals | 2 | 2004 | 27 | 0.110 |
Why?
|
| Transcription Factors | 4 | 2014 | 565 | 0.110 |
Why?
|
| Intelligence | 1 | 2014 | 58 | 0.110 |
Why?
|
| Diethylnitrosamine | 1 | 2014 | 19 | 0.110 |
Why?
|
| DNA, Complementary | 2 | 2004 | 133 | 0.110 |
Why?
|
| Acetaldehyde | 5 | 1996 | 8 | 0.110 |
Why?
|
| Bile Acids and Salts | 1 | 2014 | 78 | 0.110 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2014 | 14 | 0.110 |
Why?
|
| Epithelial Cells | 2 | 2006 | 207 | 0.110 |
Why?
|
| Adolescent | 8 | 2017 | 6447 | 0.110 |
Why?
|
| Health Status | 2 | 2009 | 299 | 0.110 |
Why?
|
| MAP Kinase Signaling System | 2 | 2011 | 117 | 0.110 |
Why?
|
| Response Elements | 2 | 2010 | 29 | 0.110 |
Why?
|
| Wnt Signaling Pathway | 1 | 2014 | 86 | 0.110 |
Why?
|
| Microarray Analysis | 3 | 2014 | 70 | 0.110 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2014 | 134 | 0.110 |
Why?
|
| Cytosol | 2 | 2005 | 78 | 0.110 |
Why?
|
| Growth and Development | 1 | 2013 | 14 | 0.110 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 3 | 2010 | 67 | 0.110 |
Why?
|
| Adipose Tissue, White | 1 | 2013 | 34 | 0.110 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2013 | 47 | 0.110 |
Why?
|
| Zea mays | 1 | 2013 | 9 | 0.110 |
Why?
|
| Stromal Cells | 1 | 2013 | 75 | 0.100 |
Why?
|
| Genome | 1 | 2013 | 65 | 0.100 |
Why?
|
| Bone Morphogenetic Protein 2 | 2 | 2012 | 45 | 0.100 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2013 | 36 | 0.100 |
Why?
|
| Oxygen | 1 | 2015 | 323 | 0.100 |
Why?
|
| Estrogen Receptor beta | 2 | 2013 | 55 | 0.100 |
Why?
|
| Skull | 4 | 2016 | 77 | 0.100 |
Why?
|
| Cell Separation | 1 | 2013 | 92 | 0.100 |
Why?
|
| Sexual Maturation | 5 | 2012 | 14 | 0.100 |
Why?
|
| Mitochondria, Liver | 1 | 2013 | 69 | 0.100 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2010 | 93 | 0.100 |
Why?
|
| Peyer's Patches | 2 | 2016 | 9 | 0.100 |
Why?
|
| Cysteamine | 5 | 1983 | 7 | 0.100 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2012 | 72 | 0.100 |
Why?
|
| Rats, Wistar | 4 | 2004 | 224 | 0.100 |
Why?
|
| Mammary Glands, Human | 1 | 2012 | 14 | 0.100 |
Why?
|
| Morphogenesis | 1 | 2012 | 13 | 0.100 |
Why?
|
| Vitamins | 1 | 2012 | 63 | 0.100 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 2012 | 30 | 0.100 |
Why?
|
| Software | 1 | 2014 | 277 | 0.100 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2014 | 213 | 0.100 |
Why?
|
| Bone Matrix | 1 | 2012 | 16 | 0.100 |
Why?
|
| Starvation | 2 | 1998 | 12 | 0.100 |
Why?
|
| Cholecalciferol | 2 | 2012 | 22 | 0.100 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2016 | 140 | 0.100 |
Why?
|
| Flavones | 1 | 2011 | 5 | 0.100 |
Why?
|
| Interleukin-8 | 2 | 2016 | 85 | 0.100 |
Why?
|
| Antifungal Agents | 1 | 1994 | 331 | 0.100 |
Why?
|
| Prenatal Nutritional Physiological Phenomena | 2 | 2014 | 9 | 0.100 |
Why?
|
| Vitamin D | 1 | 2012 | 87 | 0.100 |
Why?
|
| Kinetics | 8 | 2002 | 623 | 0.100 |
Why?
|
| Macrophage Activation | 1 | 2011 | 25 | 0.100 |
Why?
|
| Mice, Mutant Strains | 2 | 2011 | 69 | 0.100 |
Why?
|
| Receptors, Estrogen | 4 | 2013 | 132 | 0.100 |
Why?
|
| Acids, Carbocyclic | 1 | 2011 | 3 | 0.100 |
Why?
|
| Sus scrofa | 1 | 2011 | 37 | 0.090 |
Why?
|
| Foam Cells | 1 | 2011 | 16 | 0.090 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2011 | 28 | 0.090 |
Why?
|
| Fracture Healing | 2 | 2004 | 27 | 0.090 |
Why?
|
| Estrus | 3 | 2005 | 14 | 0.090 |
Why?
|
| Sirtuin 3 | 1 | 2011 | 18 | 0.090 |
Why?
|
| Scavenger Receptors, Class A | 1 | 2011 | 39 | 0.090 |
Why?
|
| Risk Factors | 3 | 2012 | 3724 | 0.090 |
Why?
|
| Homeodomain Proteins | 1 | 2011 | 79 | 0.090 |
Why?
|
| Pharmaceutical Preparations | 1 | 1992 | 76 | 0.090 |
Why?
|
| Milk Substitutes | 1 | 2010 | 5 | 0.090 |
Why?
|
| Bone Regeneration | 2 | 2005 | 74 | 0.090 |
Why?
|
| Agaricales | 1 | 2010 | 4 | 0.090 |
Why?
|
| Speech Acoustics | 1 | 2010 | 18 | 0.090 |
Why?
|
| Sign Language | 1 | 2010 | 5 | 0.090 |
Why?
|
| Disease Progression | 1 | 2014 | 829 | 0.090 |
Why?
|
| Collagen | 1 | 2012 | 204 | 0.090 |
Why?
|
| Hydroxybenzoates | 1 | 2010 | 18 | 0.090 |
Why?
|
| Oxidoreductases | 3 | 2001 | 59 | 0.090 |
Why?
|
| Fats | 1 | 2010 | 3 | 0.090 |
Why?
|
| Family Relations | 1 | 2010 | 23 | 0.090 |
Why?
|
| Arkansas | 2 | 2015 | 1984 | 0.090 |
Why?
|
| Hypophysectomy | 3 | 2000 | 3 | 0.090 |
Why?
|
| Up-Regulation | 4 | 2016 | 446 | 0.090 |
Why?
|
| Aorta | 2 | 2010 | 163 | 0.090 |
Why?
|
| Retinoid X Receptors | 1 | 2010 | 13 | 0.090 |
Why?
|
| Tissue Distribution | 2 | 2013 | 166 | 0.090 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2010 | 68 | 0.090 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2011 | 121 | 0.090 |
Why?
|
| Resistin | 1 | 2010 | 6 | 0.090 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2010 | 13 | 0.090 |
Why?
|
| Adenylate Kinase | 1 | 2010 | 9 | 0.090 |
Why?
|
| Self Concept | 1 | 2010 | 65 | 0.090 |
Why?
|
| Cytochromes b5 | 2 | 2005 | 5 | 0.090 |
Why?
|
| Allyl Compounds | 1 | 2010 | 11 | 0.090 |
Why?
|
| Molecular Sequence Data | 3 | 2006 | 778 | 0.080 |
Why?
|
| Somatostatin | 7 | 2005 | 31 | 0.080 |
Why?
|
| Sulfides | 1 | 2010 | 28 | 0.080 |
Why?
|
| RNA Interference | 2 | 2011 | 178 | 0.080 |
Why?
|
| Fibroblast Growth Factors | 1 | 2010 | 45 | 0.080 |
Why?
|
| Carbohydrate Metabolism | 1 | 2009 | 26 | 0.080 |
Why?
|
| Diet, Carbohydrate-Restricted | 1 | 2009 | 11 | 0.080 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2013 | 128 | 0.080 |
Why?
|
| Young Adult | 3 | 2019 | 4106 | 0.080 |
Why?
|
| Suicidal Ideation | 1 | 2010 | 97 | 0.080 |
Why?
|
| Chemokines | 1 | 2010 | 75 | 0.080 |
Why?
|
| Radionuclide Imaging | 1 | 2010 | 116 | 0.080 |
Why?
|
| Antibodies | 2 | 2014 | 153 | 0.080 |
Why?
|
| Regeneration | 1 | 2010 | 58 | 0.080 |
Why?
|
| Single-Blind Method | 1 | 2009 | 114 | 0.080 |
Why?
|
| Incidence | 2 | 2005 | 1032 | 0.080 |
Why?
|
| Orchiectomy | 5 | 1999 | 38 | 0.080 |
Why?
|
| Middle Aged | 9 | 2010 | 12614 | 0.080 |
Why?
|
| Endoplasmic Reticulum | 1 | 2010 | 108 | 0.080 |
Why?
|
| Prostate | 1 | 2009 | 114 | 0.080 |
Why?
|
| Calcium | 2 | 2016 | 398 | 0.080 |
Why?
|
| Pyrazoles | 1 | 2010 | 111 | 0.080 |
Why?
|
| Neuroimaging | 2 | 2020 | 87 | 0.080 |
Why?
|
| Lipopolysaccharides | 2 | 2011 | 197 | 0.080 |
Why?
|
| Gene Regulatory Networks | 1 | 2009 | 106 | 0.080 |
Why?
|
| Sexual Behavior, Animal | 2 | 1995 | 6 | 0.080 |
Why?
|
| Child Abuse | 1 | 2010 | 136 | 0.080 |
Why?
|
| Amino Acids | 4 | 1977 | 373 | 0.080 |
Why?
|
| Mice, Inbred Strains | 1 | 2008 | 160 | 0.080 |
Why?
|
| Maternal Exposure | 2 | 2001 | 96 | 0.070 |
Why?
|
| Alkaline Phosphatase | 5 | 2012 | 93 | 0.070 |
Why?
|
| Research Design | 1 | 2010 | 352 | 0.070 |
Why?
|
| Seeds | 1 | 2007 | 13 | 0.070 |
Why?
|
| Anthropometry | 2 | 2020 | 95 | 0.070 |
Why?
|
| Clinical Trials as Topic | 1 | 2010 | 486 | 0.070 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 3 | 2012 | 44 | 0.070 |
Why?
|
| Naloxone | 4 | 1982 | 81 | 0.070 |
Why?
|
| Chromatin | 2 | 2007 | 137 | 0.070 |
Why?
|
| Radioimmunoassay | 8 | 1990 | 43 | 0.070 |
Why?
|
| Severity of Illness Index | 1 | 2010 | 978 | 0.070 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 2 | 2007 | 60 | 0.070 |
Why?
|
| Tibial Fractures | 2 | 1997 | 31 | 0.070 |
Why?
|
| Predictive Value of Tests | 1 | 2010 | 929 | 0.070 |
Why?
|
| Femur | 3 | 2016 | 130 | 0.070 |
Why?
|
| Peptide Fragments | 2 | 1985 | 209 | 0.070 |
Why?
|
| Vitamin E | 1 | 2007 | 78 | 0.070 |
Why?
|
| Umbilical Veins | 1 | 2006 | 23 | 0.070 |
Why?
|
| Acoustic Stimulation | 1 | 2007 | 93 | 0.070 |
Why?
|
| Apoenzymes | 2 | 1998 | 2 | 0.070 |
Why?
|
| Chlormethiazole | 2 | 1998 | 2 | 0.070 |
Why?
|
| Stearoyl-CoA Desaturase | 1 | 2006 | 6 | 0.070 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2006 | 11 | 0.070 |
Why?
|
| Choline Deficiency | 1 | 2006 | 23 | 0.070 |
Why?
|
| Macaca fascicularis | 1 | 2006 | 10 | 0.070 |
Why?
|
| Adenocarcinoma | 2 | 2001 | 397 | 0.070 |
Why?
|
| Transforming Growth Factor beta | 3 | 2014 | 136 | 0.070 |
Why?
|
| Ileum | 2 | 2017 | 85 | 0.070 |
Why?
|
| Chemokine CXCL2 | 2 | 2017 | 11 | 0.070 |
Why?
|
| Cyclin D1 | 1 | 2006 | 52 | 0.070 |
Why?
|
| Half-Life | 2 | 2000 | 86 | 0.060 |
Why?
|
| Coculture Techniques | 1 | 2006 | 142 | 0.060 |
Why?
|
| Protein-Energy Malnutrition | 3 | 1974 | 19 | 0.060 |
Why?
|
| DNA Probes | 2 | 2004 | 29 | 0.060 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2006 | 57 | 0.060 |
Why?
|
| Cell Adhesion | 1 | 2006 | 157 | 0.060 |
Why?
|
| Naphthols | 1 | 2006 | 9 | 0.060 |
Why?
|
| Threonine | 1 | 2006 | 15 | 0.060 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2006 | 118 | 0.060 |
Why?
|
| Chromones | 1 | 2006 | 18 | 0.060 |
Why?
|
| C-Peptide | 1 | 2005 | 24 | 0.060 |
Why?
|
| Colonic Diseases | 1 | 2005 | 14 | 0.060 |
Why?
|
| AMP-Activated Protein Kinases | 2 | 2017 | 28 | 0.060 |
Why?
|
| Sulfotransferases | 1 | 2006 | 39 | 0.060 |
Why?
|
| Lymphotoxin-alpha | 1 | 2005 | 8 | 0.060 |
Why?
|
| Green Fluorescent Proteins | 1 | 2006 | 90 | 0.060 |
Why?
|
| Kupffer Cells | 1 | 2005 | 11 | 0.060 |
Why?
|
| Sensitivity and Specificity | 2 | 2012 | 861 | 0.060 |
Why?
|
| Sialoglycoproteins | 2 | 2002 | 10 | 0.060 |
Why?
|
| False Negative Reactions | 1 | 2005 | 29 | 0.060 |
Why?
|
| Subcellular Fractions | 1 | 2005 | 33 | 0.060 |
Why?
|
| Morpholines | 1 | 2006 | 66 | 0.060 |
Why?
|
| Oxidants | 1 | 2005 | 54 | 0.060 |
Why?
|
| Hydrolysis | 1 | 2005 | 64 | 0.060 |
Why?
|
| Plasmids | 1 | 2006 | 164 | 0.060 |
Why?
|
| Immune System | 1 | 2005 | 43 | 0.060 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2005 | 20 | 0.060 |
Why?
|
| Methionine | 1 | 2006 | 134 | 0.060 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2005 | 168 | 0.060 |
Why?
|
| Area Under Curve | 1 | 2005 | 179 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 3 | 2016 | 449 | 0.060 |
Why?
|
| Carbon Tetrachloride | 2 | 1995 | 22 | 0.060 |
Why?
|
| Clotrimazole | 1 | 2004 | 3 | 0.060 |
Why?
|
| Lipoproteins, LDL | 1 | 2006 | 170 | 0.060 |
Why?
|
| DNA Primers | 3 | 2014 | 206 | 0.060 |
Why?
|
| DNA Repair | 1 | 2006 | 188 | 0.060 |
Why?
|
| Immunoenzyme Techniques | 2 | 2014 | 137 | 0.060 |
Why?
|
| Cell Cycle | 1 | 2006 | 226 | 0.060 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2004 | 52 | 0.060 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2006 | 129 | 0.060 |
Why?
|
| Receptor, erbB-2 | 1 | 2004 | 74 | 0.060 |
Why?
|
| Sterol Regulatory Element Binding Protein 2 | 1 | 2004 | 2 | 0.060 |
Why?
|
| Ribonucleases | 1 | 2004 | 4 | 0.060 |
Why?
|
| Precipitin Tests | 1 | 2004 | 32 | 0.060 |
Why?
|
| Cholesterol 7-alpha-Hydroxylase | 1 | 2004 | 7 | 0.060 |
Why?
|
| Hydrocarbons, Fluorinated | 1 | 2004 | 8 | 0.060 |
Why?
|
| Nerve Tissue Proteins | 2 | 2017 | 194 | 0.060 |
Why?
|
| DNA Damage | 1 | 2006 | 301 | 0.060 |
Why?
|
| Ultraviolet Rays | 1 | 2004 | 49 | 0.060 |
Why?
|
| Hyperplasia | 1 | 2004 | 96 | 0.060 |
Why?
|
| Fatty Acids, Nonesterified | 2 | 2014 | 39 | 0.060 |
Why?
|
| Stress, Physiological | 4 | 1995 | 171 | 0.060 |
Why?
|
| Immunoblotting | 2 | 2016 | 115 | 0.060 |
Why?
|
| Fasting | 5 | 1985 | 73 | 0.060 |
Why?
|
| Postmenopause | 1 | 2004 | 96 | 0.060 |
Why?
|
| Gene Deletion | 2 | 2015 | 261 | 0.060 |
Why?
|
| STAT5 Transcription Factor | 1 | 2003 | 10 | 0.050 |
Why?
|
| Models, Genetic | 1 | 2004 | 172 | 0.050 |
Why?
|
| Janus Kinase 2 | 1 | 2003 | 22 | 0.050 |
Why?
|
| Progesterone | 4 | 2006 | 57 | 0.050 |
Why?
|
| Statistics, Nonparametric | 2 | 2001 | 192 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2017 | 1156 | 0.050 |
Why?
|
| Folic Acid | 1 | 2004 | 139 | 0.050 |
Why?
|
| Odds Ratio | 1 | 2005 | 551 | 0.050 |
Why?
|
| Calorimetry, Indirect | 2 | 2014 | 25 | 0.050 |
Why?
|
| Indicators and Reagents | 1 | 2003 | 37 | 0.050 |
Why?
|
| Sulfonamides | 1 | 2004 | 126 | 0.050 |
Why?
|
| Sodium Glutamate | 1 | 1982 | 1 | 0.050 |
Why?
|
| Glutamates | 1 | 1982 | 22 | 0.050 |
Why?
|
| Estrogen Antagonists | 1 | 2002 | 21 | 0.050 |
Why?
|
| Reproducibility of Results | 2 | 2012 | 1199 | 0.050 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2006 | 326 | 0.050 |
Why?
|
| Bone Marrow | 3 | 2012 | 363 | 0.050 |
Why?
|
| Genotype | 2 | 2014 | 533 | 0.050 |
Why?
|
| Melanoma | 1 | 2006 | 280 | 0.050 |
Why?
|
| Binding, Competitive | 1 | 2002 | 94 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 1 | 2006 | 462 | 0.050 |
Why?
|
| Trans-Activators | 1 | 2003 | 134 | 0.050 |
Why?
|
| Duodenal Neoplasms | 2 | 2005 | 15 | 0.050 |
Why?
|
| Forkhead Transcription Factors | 2 | 2013 | 110 | 0.050 |
Why?
|
| Polymorphism, Genetic | 1 | 2003 | 180 | 0.050 |
Why?
|
| Asia | 1 | 2002 | 19 | 0.050 |
Why?
|
| Vagina | 2 | 2000 | 43 | 0.050 |
Why?
|
| Oligonucleotides | 1 | 2002 | 80 | 0.050 |
Why?
|
| United States | 3 | 2016 | 4958 | 0.050 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 3 | 2010 | 39 | 0.050 |
Why?
|
| Membrane Proteins | 2 | 2014 | 332 | 0.050 |
Why?
|
| Health Promotion | 1 | 2004 | 258 | 0.050 |
Why?
|
| Spleen | 2 | 2007 | 169 | 0.050 |
Why?
|
| Fertilization | 1 | 2001 | 6 | 0.050 |
Why?
|
| Chlorzoxazone | 1 | 2000 | 5 | 0.050 |
Why?
|
| Animal Nutritional Physiological Phenomena | 3 | 2014 | 17 | 0.040 |
Why?
|
| Lipogenesis | 2 | 2013 | 28 | 0.040 |
Why?
|
| Substrate Specificity | 1 | 2000 | 192 | 0.040 |
Why?
|
| Adsorption | 1 | 2000 | 18 | 0.040 |
Why?
|
| Androstenedione | 1 | 1980 | 4 | 0.040 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 2 | 2012 | 27 | 0.040 |
Why?
|
| Nutrition Disorders | 2 | 2006 | 14 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2006 | 519 | 0.040 |
Why?
|
| NADP | 1 | 1999 | 22 | 0.040 |
Why?
|
| Administration, Intranasal | 2 | 1997 | 30 | 0.040 |
Why?
|
| Steroids | 2 | 1993 | 57 | 0.040 |
Why?
|
| Pituitary Hormone-Releasing Hormones | 3 | 1988 | 4 | 0.040 |
Why?
|
| Food-Drug Interactions | 1 | 1999 | 14 | 0.040 |
Why?
|
| Aged | 2 | 2010 | 9743 | 0.040 |
Why?
|
| Somatomedins | 2 | 2007 | 28 | 0.040 |
Why?
|
| Carrier Proteins | 2 | 2017 | 298 | 0.040 |
Why?
|
| Myelin Sheath | 1 | 2018 | 27 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2012 | 1169 | 0.040 |
Why?
|
| Fatty Acids, Essential | 1 | 1978 | 2 | 0.040 |
Why?
|
| DNA | 2 | 2007 | 535 | 0.040 |
Why?
|
| Radiography | 3 | 2010 | 486 | 0.040 |
Why?
|
| Nerve Net | 1 | 2018 | 76 | 0.040 |
Why?
|
| Acinetobacter | 1 | 2017 | 7 | 0.040 |
Why?
|
| Aminoisobutyric Acids | 1 | 2017 | 6 | 0.040 |
Why?
|
| Streptococcus | 1 | 2017 | 14 | 0.040 |
Why?
|
| Hepatocyte Nuclear Factor 1 | 1 | 1997 | 4 | 0.040 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 1 | 1997 | 5 | 0.040 |
Why?
|
| Oocyte Retrieval | 1 | 2017 | 5 | 0.040 |
Why?
|
| Clostridium | 1 | 2017 | 17 | 0.040 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 1 | 1997 | 9 | 0.040 |
Why?
|
| Ovulation Induction | 1 | 2017 | 10 | 0.040 |
Why?
|
| Glucocorticoids | 1 | 1999 | 230 | 0.040 |
Why?
|
| Inhibitor of Differentiation Proteins | 1 | 2017 | 6 | 0.040 |
Why?
|
| Dual Specificity Phosphatase 1 | 1 | 2017 | 9 | 0.040 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 1 | 1 | 2017 | 15 | 0.040 |
Why?
|
| Duodenum | 1 | 2017 | 35 | 0.040 |
Why?
|
| Carnitine | 1 | 2017 | 63 | 0.030 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2017 | 112 | 0.030 |
Why?
|
| Recombinant Proteins | 2 | 2010 | 476 | 0.030 |
Why?
|
| Barbiturates | 1 | 1977 | 17 | 0.030 |
Why?
|
| Cocarcinogenesis | 1 | 1996 | 14 | 0.030 |
Why?
|
| Single-Cell Analysis | 1 | 2017 | 63 | 0.030 |
Why?
|
| CD4-CD8 Ratio | 1 | 1996 | 9 | 0.030 |
Why?
|
| Transferrin | 1 | 1996 | 12 | 0.030 |
Why?
|
| Lymphocyte Count | 1 | 1996 | 19 | 0.030 |
Why?
|
| Antigens, Surface | 1 | 1996 | 44 | 0.030 |
Why?
|
| Mutation | 1 | 2002 | 1281 | 0.030 |
Why?
|
| Receptors, Interleukin-8A | 1 | 2016 | 6 | 0.030 |
Why?
|
| Chemokine CXCL11 | 1 | 2016 | 6 | 0.030 |
Why?
|
| Granulosa Cells | 1 | 2016 | 12 | 0.030 |
Why?
|
| Versicans | 1 | 2016 | 10 | 0.030 |
Why?
|
| Glucose Transporter Type 4 | 1 | 2016 | 23 | 0.030 |
Why?
|
| Chemokine CXCL10 | 1 | 2016 | 19 | 0.030 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2016 | 14 | 0.030 |
Why?
|
| Thinness | 1 | 2016 | 44 | 0.030 |
Why?
|
| Tissue Array Analysis | 1 | 2016 | 45 | 0.030 |
Why?
|
| Receptors, CCR2 | 1 | 2016 | 14 | 0.030 |
Why?
|
| Interleukin-9 | 1 | 2016 | 6 | 0.030 |
Why?
|
| Thymus Gland | 1 | 1996 | 42 | 0.030 |
Why?
|
| Fas Ligand Protein | 1 | 2016 | 17 | 0.030 |
Why?
|
| Leukemia Inhibitory Factor | 1 | 2016 | 13 | 0.030 |
Why?
|
| Narcotics | 1 | 1977 | 112 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2018 | 591 | 0.030 |
Why?
|
| Interleukin-15 | 1 | 2016 | 16 | 0.030 |
Why?
|
| Genetic Variation | 1 | 2017 | 207 | 0.030 |
Why?
|
| Thiazolidinediones | 1 | 2016 | 82 | 0.030 |
Why?
|
| Phencyclidine | 1 | 1996 | 35 | 0.030 |
Why?
|
| Interferon-alpha | 1 | 2016 | 47 | 0.030 |
Why?
|
| Osmolar Concentration | 2 | 1993 | 62 | 0.030 |
Why?
|
| Stress, Mechanical | 1 | 1996 | 92 | 0.030 |
Why?
|
| Jejunum | 1 | 2016 | 54 | 0.030 |
Why?
|
| Interleukin-10 | 1 | 2016 | 84 | 0.030 |
Why?
|
| Muscle, Skeletal | 2 | 2014 | 783 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 2016 | 115 | 0.030 |
Why?
|
| Corticosterone | 1 | 1995 | 18 | 0.030 |
Why?
|
| Isothiocyanates | 1 | 1995 | 19 | 0.030 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 1995 | 31 | 0.030 |
Why?
|
| Levodopa | 1 | 1995 | 44 | 0.030 |
Why?
|
| Drug Interactions | 2 | 1995 | 206 | 0.030 |
Why?
|
| Nitrophenols | 1 | 1995 | 17 | 0.030 |
Why?
|
| Genes, p53 | 1 | 1995 | 49 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2016 | 181 | 0.030 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2016 | 110 | 0.030 |
Why?
|
| Hepatectomy | 2 | 1992 | 22 | 0.030 |
Why?
|
| Butyrylcholinesterase | 1 | 1995 | 8 | 0.030 |
Why?
|
| Receptors, Tumor Necrosis Factor | 2 | 2007 | 38 | 0.030 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2014 | 19 | 0.030 |
Why?
|
| Lauric Acids | 1 | 1994 | 9 | 0.030 |
Why?
|
| Neoplasm Proteins | 1 | 2017 | 320 | 0.030 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2005 | 53 | 0.030 |
Why?
|
| Metalloproteases | 1 | 2014 | 9 | 0.030 |
Why?
|
| Matrix Metalloproteinases | 1 | 2014 | 46 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2016 | 540 | 0.030 |
Why?
|
| GTP Phosphohydrolases | 1 | 2014 | 28 | 0.030 |
Why?
|
| Actins | 1 | 2014 | 114 | 0.030 |
Why?
|
| Lysine | 2 | 2014 | 84 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2014 | 11 | 0.030 |
Why?
|
| Culture Media | 1 | 2014 | 93 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2014 | 61 | 0.030 |
Why?
|
| Drug Administration Schedule | 4 | 2002 | 370 | 0.030 |
Why?
|
| Mitochondrial Proteins | 1 | 2014 | 88 | 0.030 |
Why?
|
| Transcription Initiation Site | 1 | 2014 | 13 | 0.030 |
Why?
|
| Fibrosis | 1 | 2014 | 181 | 0.030 |
Why?
|
| Repressor Proteins | 1 | 1995 | 148 | 0.030 |
Why?
|
| Oxidoreductases Acting on Sulfur Group Donors | 1 | 2013 | 3 | 0.030 |
Why?
|
| Arginine | 1 | 1995 | 187 | 0.030 |
Why?
|
| Semaphorins | 1 | 2013 | 4 | 0.030 |
Why?
|
| Biological Clocks | 1 | 2014 | 19 | 0.030 |
Why?
|
| GATA3 Transcription Factor | 1 | 2013 | 6 | 0.030 |
Why?
|
| Cell Adhesion Molecules | 1 | 2014 | 86 | 0.030 |
Why?
|
| Pulsatile Flow | 1 | 1993 | 18 | 0.030 |
Why?
|
| Sirtuin 1 | 1 | 2014 | 28 | 0.030 |
Why?
|
| Liver Function Tests | 2 | 2008 | 45 | 0.030 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2014 | 71 | 0.030 |
Why?
|
| GPI-Linked Proteins | 1 | 2013 | 30 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 1996 | 474 | 0.030 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2014 | 90 | 0.030 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2014 | 82 | 0.030 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2014 | 57 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2014 | 111 | 0.030 |
Why?
|
| Glycoprotein Hormones, alpha Subunit | 2 | 1990 | 3 | 0.030 |
Why?
|
| Osteoprotegerin | 1 | 2013 | 54 | 0.030 |
Why?
|
| Labetalol | 1 | 1993 | 2 | 0.030 |
Why?
|
| Gonads | 1 | 1993 | 4 | 0.030 |
Why?
|
| Chorionic Gonadotropin | 2 | 1985 | 18 | 0.030 |
Why?
|
| Deuterium Oxide | 1 | 2012 | 9 | 0.030 |
Why?
|
| Air | 1 | 2012 | 22 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2013 | 161 | 0.030 |
Why?
|
| Bone Marrow Cells | 1 | 2013 | 196 | 0.030 |
Why?
|
| Activating Transcription Factor 3 | 1 | 2012 | 8 | 0.020 |
Why?
|
| GATA Transcription Factors | 1 | 2012 | 3 | 0.020 |
Why?
|
| SOX Transcription Factors | 1 | 2012 | 4 | 0.020 |
Why?
|
| Calcitonin | 1 | 2012 | 30 | 0.020 |
Why?
|
| Phytotherapy | 1 | 2012 | 45 | 0.020 |
Why?
|
| Luteolin | 1 | 2011 | 4 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 1992 | 50 | 0.020 |
Why?
|
| Arecaceae | 1 | 2011 | 4 | 0.020 |
Why?
|
| Apigenin | 1 | 2011 | 6 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2012 | 104 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2011 | 64 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2011 | 73 | 0.020 |
Why?
|
| Metabolic Diseases | 1 | 2012 | 44 | 0.020 |
Why?
|
| Histones | 1 | 2014 | 297 | 0.020 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2012 | 57 | 0.020 |
Why?
|
| Myofibrils | 1 | 2011 | 20 | 0.020 |
Why?
|
| Flavonoids | 1 | 2011 | 41 | 0.020 |
Why?
|
| Myosins | 1 | 2011 | 17 | 0.020 |
Why?
|
| Macrophages, Peritoneal | 1 | 2011 | 31 | 0.020 |
Why?
|
| Cell Shape | 1 | 2011 | 20 | 0.020 |
Why?
|
| Cell Survival | 2 | 2006 | 589 | 0.020 |
Why?
|
| Morphine | 4 | 1983 | 101 | 0.020 |
Why?
|
| Receptors, Scavenger | 1 | 2011 | 29 | 0.020 |
Why?
|
| Multiple Myeloma | 1 | 2006 | 2997 | 0.020 |
Why?
|
| Benzomorphans | 1 | 1991 | 1 | 0.020 |
Why?
|
| Opioid Peptides | 1 | 1991 | 3 | 0.020 |
Why?
|
| Cocaine | 1 | 1993 | 182 | 0.020 |
Why?
|
| Exercise | 1 | 1995 | 516 | 0.020 |
Why?
|
| Intestines | 1 | 2012 | 172 | 0.020 |
Why?
|
| Onium Compounds | 1 | 2010 | 13 | 0.020 |
Why?
|
| Drug Synergism | 1 | 1991 | 151 | 0.020 |
Why?
|
| Hedgehog Proteins | 1 | 2010 | 32 | 0.020 |
Why?
|
| Activity Cycles | 1 | 1990 | 4 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2011 | 395 | 0.020 |
Why?
|
| Gonadal Steroid Hormones | 2 | 1987 | 41 | 0.020 |
Why?
|
| Menotropins | 2 | 1980 | 3 | 0.020 |
Why?
|
| Preventive Medicine | 1 | 2010 | 22 | 0.020 |
Why?
|
| TCF Transcription Factors | 1 | 2010 | 11 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2010 | 20 | 0.020 |
Why?
|
| Biological Availability | 1 | 2010 | 102 | 0.020 |
Why?
|
| Drug Therapy | 1 | 2010 | 47 | 0.020 |
Why?
|
| Fourier Analysis | 1 | 2010 | 18 | 0.020 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2010 | 13 | 0.020 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2010 | 44 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2010 | 83 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 1991 | 574 | 0.020 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2010 | 66 | 0.020 |
Why?
|
| Solubility | 1 | 2010 | 71 | 0.020 |
Why?
|
| Scalp | 1 | 2010 | 40 | 0.020 |
Why?
|
| Biomedical Research | 1 | 2012 | 244 | 0.020 |
Why?
|
| beta-Galactosidase | 1 | 2009 | 32 | 0.020 |
Why?
|
| Cerebellum | 3 | 1975 | 131 | 0.020 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 1 | 2008 | 13 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2009 | 88 | 0.020 |
Why?
|
| Wound Healing | 1 | 2010 | 186 | 0.020 |
Why?
|
| Leydig Cells | 2 | 1985 | 7 | 0.020 |
Why?
|
| Ligands | 1 | 2009 | 203 | 0.020 |
Why?
|
| Eating | 1 | 2009 | 158 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2011 | 372 | 0.020 |
Why?
|
| Perfusion | 2 | 1986 | 49 | 0.020 |
Why?
|
| Free Radical Scavengers | 1 | 2008 | 25 | 0.020 |
Why?
|
| Autoantibodies | 1 | 2008 | 115 | 0.020 |
Why?
|
| Mitochondria | 1 | 2011 | 399 | 0.020 |
Why?
|
| Calcitriol | 1 | 2007 | 39 | 0.020 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2007 | 19 | 0.020 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2007 | 17 | 0.020 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2007 | 20 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2007 | 49 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2007 | 50 | 0.020 |
Why?
|
| STAT3 Transcription Factor | 1 | 2007 | 77 | 0.020 |
Why?
|
| Appetite Regulation | 1 | 2007 | 12 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2008 | 218 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2012 | 1609 | 0.020 |
Why?
|
| TNF Receptor-Associated Factor 1 | 1 | 2007 | 3 | 0.020 |
Why?
|
| Brain Chemistry | 1 | 2007 | 69 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2007 | 158 | 0.020 |
Why?
|
| Rats, Mutant Strains | 1 | 1986 | 9 | 0.020 |
Why?
|
| Osteotomy | 1 | 2007 | 31 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2008 | 181 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2018 | 6263 | 0.020 |
Why?
|
| Rats, Zucker | 1 | 1986 | 68 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2006 | 80 | 0.020 |
Why?
|
| Intestinal Mucosa | 1 | 2007 | 216 | 0.020 |
Why?
|
| Proestrus | 1 | 1986 | 1 | 0.020 |
Why?
|
| Blood Glucose | 2 | 2007 | 447 | 0.020 |
Why?
|
| Nervous System Neoplasms | 1 | 1986 | 5 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2006 | 164 | 0.020 |
Why?
|
| Choristoma | 1 | 2005 | 24 | 0.020 |
Why?
|
| Myometrium | 1 | 2005 | 13 | 0.020 |
Why?
|
| Injections, Subcutaneous | 1 | 1985 | 52 | 0.020 |
Why?
|
| Chondrocytes | 1 | 2005 | 40 | 0.020 |
Why?
|
| Biological Assay | 2 | 1986 | 45 | 0.020 |
Why?
|
| Neurofibromatosis 1 | 1 | 1986 | 32 | 0.020 |
Why?
|
| Endometrium | 1 | 2005 | 40 | 0.020 |
Why?
|
| Epithelium | 1 | 2005 | 66 | 0.020 |
Why?
|
| Tamoxifen | 1 | 1986 | 60 | 0.020 |
Why?
|
| Gonadotropins, Pituitary | 1 | 1985 | 3 | 0.020 |
Why?
|
| Ketones | 1 | 1985 | 9 | 0.020 |
Why?
|
| Testolactone | 1 | 1985 | 1 | 0.020 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 1985 | 9 | 0.020 |
Why?
|
| Aromatase Inhibitors | 1 | 1985 | 17 | 0.020 |
Why?
|
| Puberty, Precocious | 1 | 1985 | 6 | 0.020 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2005 | 29 | 0.010 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2004 | 23 | 0.010 |
Why?
|
| Bony Callus | 1 | 2004 | 4 | 0.010 |
Why?
|
| Protein Deficiency | 2 | 1974 | 7 | 0.010 |
Why?
|
| Autoanalysis | 2 | 1974 | 6 | 0.010 |
Why?
|
| Somatostatin-28 | 1 | 1984 | 3 | 0.010 |
Why?
|
| Chromatography, Gel | 2 | 1982 | 40 | 0.010 |
Why?
|
| Menopause | 1 | 1985 | 55 | 0.010 |
Why?
|
| Brain Stem | 2 | 1975 | 57 | 0.010 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2005 | 131 | 0.010 |
Why?
|
| Meat | 1 | 2004 | 60 | 0.010 |
Why?
|
| Hemostasis | 1 | 2004 | 59 | 0.010 |
Why?
|
| Homocysteine | 1 | 2004 | 127 | 0.010 |
Why?
|
| Molecular Structure | 1 | 2005 | 296 | 0.010 |
Why?
|
| Cross-Over Studies | 1 | 2004 | 228 | 0.010 |
Why?
|
| Prolactin | 1 | 1983 | 44 | 0.010 |
Why?
|
| Terminology as Topic | 1 | 2004 | 67 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2014 | 5285 | 0.010 |
Why?
|
| Research | 1 | 2004 | 106 | 0.010 |
Why?
|
| Endorphins | 1 | 1983 | 1 | 0.010 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2002 | 15 | 0.010 |
Why?
|
| N-Methylaspartate | 1 | 1982 | 27 | 0.010 |
Why?
|
| Thyrotropin | 1 | 1983 | 49 | 0.010 |
Why?
|
| Aspartic Acid | 1 | 1982 | 50 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2006 | 511 | 0.010 |
Why?
|
| Blood Proteins | 3 | 1978 | 84 | 0.010 |
Why?
|
| Osteopontin | 1 | 2002 | 15 | 0.010 |
Why?
|
| Intubation, Gastrointestinal | 1 | 2002 | 28 | 0.010 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2001 | 14 | 0.010 |
Why?
|
| Microscopy, Video | 1 | 2001 | 13 | 0.010 |
Why?
|
| External Fixators | 1 | 2001 | 9 | 0.010 |
Why?
|
| Central Nervous System | 1 | 1982 | 83 | 0.010 |
Why?
|
| Spiperone | 1 | 1981 | 4 | 0.010 |
Why?
|
| Ejaculation | 1 | 1981 | 15 | 0.010 |
Why?
|
| Periosteum | 1 | 2001 | 26 | 0.010 |
Why?
|
| Calcification, Physiologic | 1 | 2001 | 40 | 0.010 |
Why?
|
| Tensile Strength | 1 | 2001 | 30 | 0.010 |
Why?
|
| Blood Urea Nitrogen | 2 | 1978 | 39 | 0.010 |
Why?
|
| L-Lactate Dehydrogenase | 2 | 1978 | 60 | 0.010 |
Why?
|
| Alcohol Oxidoreductases | 1 | 1980 | 13 | 0.010 |
Why?
|
| Amenorrhea | 1 | 1980 | 1 | 0.010 |
Why?
|
| Pregnenolone | 1 | 1980 | 1 | 0.010 |
Why?
|
| Running | 1 | 1980 | 17 | 0.010 |
Why?
|
| Biotransformation | 1 | 1980 | 84 | 0.010 |
Why?
|
| Sports Medicine | 1 | 1980 | 20 | 0.010 |
Why?
|
| Dihydrotestosterone | 2 | 1990 | 12 | 0.010 |
Why?
|
| Follicle Stimulating Hormone, beta Subunit | 2 | 1990 | 4 | 0.010 |
Why?
|
| Nucleic Acid Hybridization | 2 | 1990 | 55 | 0.010 |
Why?
|
| Interleukins | 1 | 1998 | 31 | 0.010 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 1997 | 28 | 0.010 |
Why?
|
| Thymidine | 1 | 1997 | 16 | 0.010 |
Why?
|
| Tritium | 1 | 1997 | 47 | 0.010 |
Why?
|
| Ammonium Chloride | 1 | 1977 | 4 | 0.010 |
Why?
|
| Histidine | 1 | 1977 | 15 | 0.010 |
Why?
|
| Orthopedic Equipment | 1 | 1997 | 3 | 0.010 |
Why?
|
| Injections, Intraperitoneal | 1 | 1977 | 59 | 0.010 |
Why?
|
| Median Eminence | 2 | 1989 | 8 | 0.010 |
Why?
|
| Carbon Tetrachloride Poisoning | 1 | 1996 | 3 | 0.010 |
Why?
|
| Galactosamine | 1 | 1996 | 4 | 0.010 |
Why?
|
| Drug Tolerance | 1 | 1977 | 60 | 0.010 |
Why?
|
| Embryonic and Fetal Development | 1 | 1996 | 18 | 0.010 |
Why?
|
| Equipment Design | 1 | 1997 | 289 | 0.010 |
Why?
|
| Goats | 1 | 1995 | 11 | 0.010 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 1977 | 168 | 0.010 |
Why?
|
| Oligonucleotide Probes | 1 | 1995 | 20 | 0.010 |
Why?
|
| Adrenal Glands | 1 | 1995 | 40 | 0.010 |
Why?
|
| Kwashiorkor | 1 | 1974 | 3 | 0.010 |
Why?
|
| Adaptation, Physiological | 1 | 1995 | 93 | 0.010 |
Why?
|
| Rabbits | 1 | 1995 | 372 | 0.010 |
Why?
|
| Immune Sera | 2 | 1985 | 15 | 0.010 |
Why?
|
| Protein Binding | 1 | 1996 | 654 | 0.010 |
Why?
|
| Diencephalon | 1 | 1972 | 1 | 0.010 |
Why?
|
| Telencephalon | 1 | 1972 | 2 | 0.010 |
Why?
|
| Drinking Behavior | 1 | 1972 | 6 | 0.010 |
Why?
|
| Blood | 1 | 1972 | 25 | 0.010 |
Why?
|
| Eye | 1 | 1972 | 24 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 1993 | 145 | 0.010 |
Why?
|
| Myocardium | 1 | 1972 | 445 | 0.010 |
Why?
|
| Pituitary Hormones, Anterior | 1 | 1988 | 4 | 0.000 |
Why?
|
| Infusion Pumps | 1 | 1988 | 13 | 0.000 |
Why?
|
| Protein Biosynthesis | 1 | 1990 | 232 | 0.000 |
Why?
|
| Spermatogenesis | 1 | 1986 | 9 | 0.000 |
Why?
|
| Schwann Cells | 1 | 1986 | 13 | 0.000 |
Why?
|
| Ditiocarb | 1 | 1985 | 1 | 0.000 |
Why?
|
| Pituitary Function Tests | 1 | 1985 | 1 | 0.000 |
Why?
|
| Kidney Function Tests | 1 | 1985 | 51 | 0.000 |
Why?
|
| Kidney Tubules | 1 | 1985 | 61 | 0.000 |
Why?
|
| Domperidone | 1 | 1983 | 1 | 0.000 |
Why?
|
| Receptors, Dopamine | 1 | 1983 | 21 | 0.000 |
Why?
|
| Thyrotropin-Releasing Hormone | 1 | 1983 | 5 | 0.000 |
Why?
|
| beta-Endorphin | 1 | 1983 | 7 | 0.000 |
Why?
|
| Substance P | 1 | 1983 | 28 | 0.000 |
Why?
|
| Clonidine | 1 | 1983 | 25 | 0.000 |
Why?
|
| Norepinephrine | 1 | 1983 | 114 | 0.000 |
Why?
|
| Dopamine | 1 | 1983 | 175 | 0.000 |
Why?
|
| Food | 1 | 1981 | 66 | 0.000 |
Why?
|
| Endocrine System Diseases | 1 | 1980 | 9 | 0.000 |
Why?
|
| Methylhistidines | 1 | 1977 | 8 | 0.000 |
Why?
|
| Globins | 1 | 1977 | 12 | 0.000 |
Why?
|
| Nitrogen | 1 | 1977 | 70 | 0.000 |
Why?
|
| Amino Acids, Essential | 1 | 1977 | 133 | 0.000 |
Why?
|
| Aspartate Aminotransferases | 1 | 1972 | 43 | 0.000 |
Why?
|
| Blood Cell Count | 1 | 1972 | 39 | 0.000 |
Why?
|
| Hematocrit | 1 | 1972 | 43 | 0.000 |
Why?
|
| Electrolytes | 1 | 1972 | 27 | 0.000 |
Why?
|
| Creatinine | 1 | 1972 | 145 | 0.000 |
Why?
|
| Hemoglobins | 1 | 1972 | 109 | 0.000 |
Why?
|